{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:40Z","timestamp":1790741800446,"version":"4.1.0"},"reference-count":24,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive pulmonary aspergillosis (IPA) has become a recognizable complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Alveolar damage in the context of acute respiratory distress syndrome (ARDS) appears to be the culprit in facilitating fungal invasion in COVID-19 patients, leading to a COVID-19-associated pulmonary aspergillosis (CAPA) phenomenon. From November 2020 to 15 February 2021, 248 COVID-19 patients were admitted to our ICUs, of whom ten patients (4% incidence) were classified as either probable (six) or possible (four) CAPA cases. Seven patients had positive cultural results: Aspergillus fumigatus sensu stricto (five), A. terreus sensu stricto (one), and A. welwitschiae (one). Five patients had positive bronchoalveolar lavage (BAL) and galactomannan (GM), and two patients had both positive cultural and GM criteria. All but two patients received voriconazole. Mortality rate was 30%. Strict interpretation of classic IPA definition would have resulted in eight overlooked CAPA cases. Broader diagnostic criteria are essential in this context, even though differentiation between Aspergillus colonization and invasive disease might be more challenging. Herein, we aim to raise awareness of CAPA in view of its potential detrimental outcome, emphasizing the relevance of a low threshold for screening and early antifungal treatment in ARDS patients.<\/jats:p>","DOI":"10.3390\/jof7100881","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T03:01:13Z","timestamp":1634698873000},"page":"881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital"],"prefix":"10.3390","volume":"7","author":[{"given":"David","family":"Ranhel","sequence":"first","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judite","family":"Batista","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pessanha","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete","family":"Cristovam","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Duarte","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Dias","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Coelho","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Freire","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ver\u00edssimo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, National Health Institute Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6585-7775","authenticated-orcid":false,"given":"Raquel","family":"Sabino","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, National Health Institute Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal"},{"name":"Instituto de Sa\u00fade Ambiental, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4674-6065","authenticated-orcid":false,"given":"Cristina","family":"Toscano","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental, 1349-019 Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and Managing COVID-19-Associated Pulmonary Aspergillosis: The 2020 ECMM\/ISHAM Consensus Criteria for Research and Clinical Guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid2701.202896","article-title":"Aspergillosis Complicating Severe Coronavirus Disease","volume":"27","author":"Marr","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/myc.12869","article-title":"Developing Definitions for Invasive Fungal Diseases in Critically Ill Adult Patients in Intensive Care Units. Protocol of the FUN Gal Infections Definitions in ICU Patients (FUNDICU) Project","volume":"62","author":"Bassetti","year":"2019","journal-title":"Mycoses"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit with Severe Influenza: A Retrospective Cohort Study","volume":"6","author":"Alexander","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of Influenza-Associated Pulmonary Aspergillosis in ICU Patients and Proposal for a Case Definition: An Expert Opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 Associated Pulmonary Aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill Patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/myc.13135","article-title":"COVID-19-associated Pulmonary Aspergillosis (CAPA) in Patients Admitted with Severe COVID-19 Pneumonia: An Observational Study from Pakistan","volume":"63","author":"Nasir","year":"2020","journal-title":"Mycoses"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., Van De Veerdonk, F.L., Jenks, J.D., Koehler, P., Krause, R., Cornely, O.A., Perlin, D.S., Lass-Fl\u00f6rl, C., and Hoenigl, M. (2020). COVID-19 Associated Pulmonary Aspergillosis (CAPA)\u2014From Immunology to Treatment. J. Fungi, 6.","DOI":"10.3390\/jof6020091"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gangneux, J.-P., Reizine, F., Guegan, H., Pinceaux, K., Le Balch, P., Prat, E., Pelletier, R., Belaz, S., Le Souhaitier, M., and Le Tulzo, Y. (2020). Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience. J. Fungi, 6.","DOI":"10.3390\/jof6030105"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3201\/eid2607.201603","article-title":"Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient","volume":"26","author":"Blaize","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-Associated Pulmonary Aspergillosis","volume":"202","author":"Rijpstra","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-Associated Pulmonary Aspergillosis, March-August 2020","volume":"27","author":"Sprute","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mmcr.2020.06.005","article-title":"Multi-Triazole-Resistant Aspergillus Fumigatus and SARS-CoV-2 Co-Infection: A Lethal Combination","volume":"31","author":"Mohamed","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mmcr.2020.06.006","article-title":"Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU\u2013A case report","volume":"31","author":"Saade","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sabino, R., Gon\u00e7alves, P., Martins Melo, A., Sim\u00f5es, D., Oliveira, M., Francisco, M., Viegas, C., Carvalho, D., Martins, C., and Ferreira, T. (2021). Trends on Aspergillus Epidemiology\u2014Perspectives from a National Reference Laboratory Surveillance Program. J. Fungi, 7.","DOI":"10.3390\/jof7010028"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2666-5247(20)30127-0","article-title":"COVID-19 and Fungal Infection: The Need for a Strategic Approach","volume":"1","author":"White","year":"2020","journal-title":"Lancet Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jmii.2020.09.004","article-title":"COVID-19 Associated with Pulmonary Aspergillosis: A Literature Review","volume":"54","author":"Lai","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lahmer, T., Kriescher, S., Herner, A., Rothe, K., Spinner, C.D., Schneider, J., Mayer, U., Neuenhahn, M., Hoffmann, D., and Geisler, F. (2021). Invasive Pulmonary Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia: Results from the Prospective AspCOVID-19 Study. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0238825"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1080\/13693780802227159","article-title":"Invasive Aspergillosis in Glucocorticoid-Treated Patients","volume":"47","author":"Lewis","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne, J.A.C., Murthy, S., Diaz, J.V., Slutsky, A.S., Villar, J., Angus, D.C., Annane, D., Azevedo, L.C.P., and Berwanger, O. (2020). Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-Analysis. JAMA, 324, 1330.","DOI":"10.1001\/jama.2020.17023"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Meijer, E., Dofferhoff, A., Hoiting, O., Buil, J., and Meis, J. (2020). Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report. J. Fungi, 6.","DOI":"10.3390\/jof6020079"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mohamed, A., Rogers, T.R., and Talento, A.F. (2020). COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges. J. Fungi, 6.","DOI":"10.3390\/jof6030115"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/10\/881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:18:03Z","timestamp":1760167083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/10\/881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jof7100881"],"URL":"https:\/\/doi.org\/10.3390\/jof7100881","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]}}}